Skip to content

Andromachus the Elder and Andromachus the Younger

Professional services

UnclaimedRequest correction

A father-and-son pair of Greek physicians associated with the court of Nero and the development and transmission of theriac.

Last updated August 26, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Andromachus the Elder and Andromachus the Younger were two Greek physicians of the first century, generally identified as father and son and associated with the imperial world of Nero. Their historical importance rests less on a continuous biography than on their influence on ancient pharmacology, especially the preparation known as theriac or mithridate. The Elder is described as having been born in Crete and as serving as physician to the emperor Nero during the period 54–68 CE. He is also associated with the earliest known use of the title archiater, a designation later used for a chief or senior physician attached to a ruler or civic institution. Andromachus the Elder became particularly renowned for revising an earlier compound antidote traditionally linked with Mithridates VI of Pontus. After considering the protective properties attributed to snake flesh, he formulated a version of the remedy that became known as theriac. The preparation was a complex electuary made from numerous ingredients and was believed in antiquity to counter poisoning and other illnesses. Its reputation lasted for many centuries, although its composition and medical value varied across periods and formularies. The Elder set out instructions for preparing the compound in a Greek elegiac poem of 174 lines dedicated to Nero. According to Galen, verse made the recipe easier to memorize and helped reduce the risk of textual alteration compared with prose transmission. Galen preserved and discussed the poem in two of his works, making the Elder an important intermediary in the history of Greco-Roman pharmacological writing. Later medical authors also debated his precise role. The fifteenth-century physician Saladino d'Ascoli argued that Andromachus, rather than Galen, should be credited with creating theriac, responding to a competing attribution found in the Antidotarium Nicolai tradition. This later debate illustrates how the Elder's name continued to function as an authority in the history of antidotal medicine. Very little is known about Andromachus the Younger. He was the Elder's son and may also have served as an imperial physician, although the evidence is uncertain. He is generally credited with a pharmaceutical work in three books. The work itself has not survived intact; only fragments and quotations remain. Galen cited it frequently and approvingly, suggesting that it was regarded as a useful authority in ancient medical literature. Some older references have alternatively associated the Elder with a pharmaceutical treatise, but modern summaries commonly assign the three-book work to the Younger. The pair therefore represent two related but distinct forms of medical authority: the Elder as a court physician, named archiater, and composer of a memorable antidote recipe; and the Younger as a largely undocumented pharmaceutical author whose work was preserved indirectly through later writers. They are not a modern commercial brand or continuing organization. Their inclusion in histories of medicine derives from their place in the transmission of ancient pharmacology, the development of compound remedies, and the long cultural history of theriac.

History

The name Andromachus in the history of medicine refers to two Greek physicians of the first century CE, conventionally distinguished as the Elder and the Younger. Ancient and later sources present them as father and son, though the surviving evidence is insufficient to reconstruct a full family history or a precise chronology for either man. Their careers belong to the medical culture of the Roman imperial period, when Greek physicians were prominent at elite courts and when compound drugs were increasingly described, collected, and transmitted through literary works. The Elder is associated with Crete by birth and with the court of Nero. He is generally dated to Nero's reign, from 54 to 68 CE, and is often identified as the earliest person for whom the title archiater is documented. The term came to denote a senior physician, particularly one attached to a ruler or public institution. His court position gave him status within the Roman imperial medical environment, but the surviving accounts preserve more information about his pharmaceutical reputation than about his personal life or clinical practice. His principal historical legacy is theriac, a celebrated compound antidote also connected with the older tradition of mithridate. Ancient antidotal recipes were mixtures of many substances and were believed to protect against poisons. The Elder reportedly modified an earlier formula after recognizing or accepting claims about the anti-toxic properties of snake flesh. The resulting preparation acquired a durable reputation and was attributed to him in later medical traditions. Theriac subsequently remained important in pharmacological writing for centuries, although recipes changed considerably and later practitioners did not necessarily agree on its ingredients or effects. Rather than recording the recipe in ordinary prose, the Elder composed directions in a Greek elegiac poem of 174 lines and dedicated the work to Nero. Galen preserved the poem in two of his medical writings. He explained that verse could assist memorization and make unauthorized alteration less likely. The poem's survival through Galen helped establish the Elder as a named authority in the history of antidotal medicine, even though the complete context of the original composition is not available. The attribution of theriac later became a subject of scholarly and medical debate. The fifteenth-century physician Saladino d'Ascoli maintained that Andromachus, rather than Galen, deserved credit for creating the preparation. This position was directed against an attribution associated with the Antidotarium Nicolai tradition. The dispute reflects the way medieval and early modern physicians used ancient names to establish the authority and lineage of pharmaceutical recipes. The Younger is much less securely documented. He was identified as the Elder's son and may also have held an imperial medical appointment, but no reliable narrative of his life survives. He is commonly regarded as the author of a pharmaceutical treatise in three books. The original work is lost, with only fragments and quotations remaining. Galen cited it repeatedly and favorably, indicating that it was known as a substantial source of pharmaceutical learning in antiquity. The precise boundaries between the works of the father and son are not always certain, and some earlier commentators assigned pharmaceutical authorship to the Elder instead. Together, the two Andromachi illustrate how ancient medical reputations were preserved through later authors rather than through complete biographies. The Elder is remembered as a court physician, an early archiater, and the named formulator of a famous antidote. The Younger is remembered mainly through the fragments of a pharmaceutical text cited by Galen. Their legacy belongs to the history of medicine and pharmacy, not to an ongoing institution, enterprise, or commercial brand.

  • Andromachus the Elder is associated with Nero's court

    [1]

    The Elder is described as serving as physician to Nero during the emperor's reign, which began in 54 CE.

  • End of the Elder's documented association with Nero

    [1]

    The period traditionally given for the Elder's service to Nero ends with Nero's reign in 68 CE.

  • The Elder's theriac poem is composed

    [1]

    Andromachus the Elder is credited with composing a 174-line Greek elegiac poem describing the preparation of his antidotal compound and dedicating it to Nero.

  • Galen preserves the Elder's recipe and cites the Younger's work

    [1]

    Galen incorporated the Elder's poetic directions into two works and frequently cited the Younger’s pharmaceutical writings, allowing parts of both legacies to survive.

  • Later physicians debate authorship of theriac

    [1]

    Medieval and early modern medical authors, including Saladino d'Ascoli, disputed whether Andromachus or Galen should receive credit for the antidote's creation.

Products and positioning

Historical Greco-Roman medical practitioners and pharmaceutical authorities, remembered primarily for antidotal medicine and the transmission of compound-drug knowledge.

  • Compound antidote and electuary

    Theriac

    Theriac was a complex compound remedy intended in ancient medicine to counter poisons and treat other ailments. The preparation was connected with the earlier mithridate tradition, but the version associated with Andromachus the Elder was presented as a revised formula incorporating snake flesh. Its ingredients and proportions changed over time, and its fame continued long after the original physician's lifetime. The Elder's instructions were preserved in a 174-line Greek elegiac poem.

  • Pharmaceutical treatise

    Pharmaceutical work in three books

    A pharmaceutical work in three books is generally attributed to Andromachus the Younger. The complete text has been lost, but fragments and quotations survived through later medical authors. Galen cited the work repeatedly and with approval, making it an important indirect source for understanding ancient pharmaceutical knowledge.

Brand decisions

  • Development of a revised theriac formulaProduct launch

    Background

    The Elder was associated with the older mithridate tradition and with claims that snake flesh possessed anti-toxic properties.

    Action taken

    He is credited with modifying the compound antidote and documenting its preparation in an elegiac poem dedicated to Nero.

    Aftermath

    The preparation became famous under his name and remained influential in later antidotal and pharmaceutical traditions.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/andromachus-the-elder-and-andromachus-the-younger · Editorial policy · How profiles are compiled